Filing Details
- Accession Number:
- 0001104659-23-037190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-27 17:17:23
- Reporting Period:
- 2023-03-23
- Accepted Time:
- 2023-03-27 17:17:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326190 | Altimmune Inc. | ALT | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428764 | David Drutz | C/O Altimmune, Inc., 910 Clopper Road, Suite 201S Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2023-03-23 | 9,000 | $4.27 | 29,484 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.265 to $4.28, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes 20,151 shares of Common Stock previously owned directly by the reporting person which were transferred to Pacific Biopharma Associates, LLC.
- Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.
Billionaire Hedge Funds
